GlaxoSmithKline, Europe’s largest drugmaker, named 43-year-old Briton Andrew Witty as its new chief executive. Witty takes the helm from Frenchman Jean-Pierre Garnier next May. “He has the luxury of time, since he could be there for the best part of 20 years,” said analyst Peter Cartwright at Evolution Securities. (Reuters)
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
SUBSCRIBE & SAVE
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
